189 related articles for article (PubMed ID: 9579641)
1. Therapeutic use of antithrombin concentrate in sepsis.
Balk R; Emerson T; Fourrier F; Kruse JA; Mammen EF; Schuster HP; Vinazzer H
Semin Thromb Hemost; 1998; 24(2):183-94. PubMed ID: 9579641
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of antithrombin concentrate use in patients with disseminated intravascular coagulation of severe sepsis.
Wiedermann CJ; Kaneider NC
Blood Coagul Fibrinolysis; 2006 Oct; 17(7):521-6. PubMed ID: 16988545
[TBL] [Abstract][Full Text] [Related]
3. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
4. Coagulation inhibitors in sepsis and disseminated intravascular coagulation.
Lee WL; Downey GP
Intensive Care Med; 2000 Nov; 26(11):1701-6. PubMed ID: 11193281
[TBL] [Abstract][Full Text] [Related]
5. Antithrombin III supplementation in severe sepsis: beneficial effects on organ dysfunction.
Inthorn D; Hoffmann JN; Hartl WH; Mühlbayer D; Jochum M
Shock; 1997 Nov; 8(5):328-34. PubMed ID: 9361342
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III replacement in animal models of acquired antithrombin III deficiency.
Emerson TE
Blood Coagul Fibrinolysis; 1994 Jan; 5 Suppl 1():S37-45; discussion S59-64. PubMed ID: 8186355
[TBL] [Abstract][Full Text] [Related]
7. [The clinical efficacy of antithrombin III concentrate in infections complicated by DIC].
Kobayashi H; Kawai S; Oshitani H; Tamakuma S; Hayasaka H; Akiyama M; Nakamura T; Hashimoto I; Sawada Y; Takebe K
Kansenshogaku Zasshi; 1985 Nov; 59(11):1121-34. PubMed ID: 3938461
[No Abstract] [Full Text] [Related]
8. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
Kuroda H; Masuda Y
Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
[TBL] [Abstract][Full Text] [Related]
9. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
10. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
[TBL] [Abstract][Full Text] [Related]
11. Present and future of anticoagulant therapy using antithrombin and thrombomodulin for sepsis-associated disseminated intravascular coagulation: a perspective from Japan.
Iba T; Thachil J
Int J Hematol; 2016 Mar; 103(3):253-61. PubMed ID: 26588929
[TBL] [Abstract][Full Text] [Related]
12. Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
Mesters RM; Mannucci PM; Coppola R; Keller T; Ostermann H; Kienast J
Blood; 1996 Aug; 88(3):881-6. PubMed ID: 8704245
[TBL] [Abstract][Full Text] [Related]
13. Pathogenesis and treatment of disseminated intravascular coagulation in the septic patient.
Levi M
J Crit Care; 2001 Dec; 16(4):167-77. PubMed ID: 11815902
[TBL] [Abstract][Full Text] [Related]
14. Antithrombin III in Sepsis. New evidences and open questions.
Ostermann H
Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin concentrate use in sepsis-associated disseminated intravascular coagulation: re-evaluation of a 'pendulum effect' drug using a nationwide database.
Tagami T
J Thromb Haemost; 2018 Mar; 16(3):458-461. PubMed ID: 29316251
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
Bahrami S; Paul E; Redl H; Schlag G
Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
[No Abstract] [Full Text] [Related]
17. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
[TBL] [Abstract][Full Text] [Related]
18. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
Jespersen J; Rasmussen NR; Sidelmann J
Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
[No Abstract] [Full Text] [Related]
19. Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.
Warren BL; Eid A; Singer P; Pillay SS; Carl P; Novak I; Chalupa P; Atherstone A; Pénzes I; Kübler A; Knaub S; Keinecke HO; Heinrichs H; Schindel F; Juers M; Bone RC; Opal SM;
JAMA; 2001 Oct; 286(15):1869-78. PubMed ID: 11597289
[TBL] [Abstract][Full Text] [Related]
20. [[Antithrombin III concentrates in the treatmetn of sepsis and septic shock: indictions, limits and future prospects] ].
Baudo F; de Cataldo F
Minerva Anestesiol; 2000 Nov; 66(11 Suppl 1):3-23. PubMed ID: 11213542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
